Attila Fintha

1.0k citations
39 papers · 763 indexed · h-index 14
Topics
Renal and related cancers (5 papers)Renin-Angiotensin System Studies (5 papers)Chronic Kidney Disease and Diabetes (4 papers)

In The Last Decade

Attila Fintha

36 papers receiving 753 citations

Peers

Attila Fintha
Comparison fields: 5 of 78
  • Molecular Biology 363
  • Cardiology and Cardiovascular Medicine 162
  • Genetics 128
  • Endocrinology, Diabetes and Metabolism 123
  • Nephrology 107
Replace Tetsuo Morioka with:
Tetsuo Morioka Japan
Sobuj Mia Germany
Sara S. Roscioni Netherlands
Hisato Sakamoto Japan
Lihe Chen United States
Samantha Moore United Kingdom
Marko Bertog Germany
Michael Reiner Germany
Zhizhen Lü China
Dursun Gündüz Germany
Attila Fintha relative to Tetsuo Morioka Japan Tetsuo Morioka's profile →
Citations per field
00.5×4.8×
Tetsuo Morioka · 1×
Citations per year

Countries citing papers authored by Attila Fintha

Since Specialization
Citations

This map shows the geographic impact of Attila Fintha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Attila Fintha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Attila Fintha more than expected).

Fields of papers citing papers by Attila Fintha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Attila Fintha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Attila Fintha. The network helps show where Attila Fintha may publish in the future.

Co-authorship network of co-authors of Attila Fintha

This figure shows the co-authorship network connecting the top 25 collaborators of Attila Fintha. A scholar is included among the top collaborators of Attila Fintha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Attila Fintha. Attila Fintha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 5
5 7
6 3
7 4
8 2
9 5
10 11
11 1
12 41
13 11
14 54
15 13
16 9
17 2
18 76
19 6
20 72

About Attila Fintha

Attila Fintha is a scholar working on Nephrology, Transplantation and Physiology, having authored 39 papers that have together received 763 indexed citations. Recurring topics across this work include Renal and related cancers (5 papers), Renin-Angiotensin System Studies (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). The work is most often cited by research in Physiology (79 citations), Nephrology (107 citations) and Endocrinology, Diabetes and Metabolism (123 citations). Attila Fintha has collaborated with scholars based in Hungary, United States and Austria. Frequent co-authors include Péter Komlósi, P. Darwin Bell, László Rosivall, Amanda L. Fuson, János Peti‐Peterdi, P. Darwin Bell, Attila Sebe, Ákos Gasparics, Albert Tousson and Bradley K. Yoder. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026